Skip to main content
Equibles

SILVERARC CAPITAL MANAGEMENT, LLC

Position in VCYT — Veracyte, Inc.

CIK 1816307 BOSTON, MA
Back to VCYT Full portfolio

Position in VCYT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,676,198
+$12,888,061 QoQ
Shares Held
318,001
+77.0% QoQ
Ownership
0.396%
of shares outstanding
% of Portfolio
2.08%
of 13F equity value
Holder Rank
#51
of 367 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCYT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

SILVERARC CAPITAL MANAGEMENT, LLC holds $42,046,858 across 3 Diagnostics & Research names. VCYT ranks #1 (44.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VCYT
Veracyte, Inc.
This page 		318,001 $18,676,198
2 GH
Guardant Health, Inc.
 99,826 $14,976,894
3 WGS
GeneDx Holdings Corp.
 122,269 $8,393,766

All Filings in VCYT

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,676,198 318,001
2026-03-31 $5,788,137 179,700
2025-12-31 $15,053,191 357,558
2025-09-30 $8,094,705 235,791
2025-06-30 $12,122,819 448,495
2025-03-31 $18,793,118 633,832
2024-12-31 $19,929,927 503,281
2024-09-30 $16,018,032 470,565
2024-06-30 $6,116,314 282,248
2024-03-31 $6,221,929 280,773
2023-12-31 $6,814,859 247,723
2023-09-30 $5,349,620 239,571
2023-06-30 $5,844,116 229,451
2023-03-31 $4,675,261 209,653
2022-12-31 $4,746,000 200,000
2022-09-30 $11,053,176 665,854
2022-06-30 $14,303,901 718,789
2022-03-31 $11,732,523 425,554
2021-12-31 $9,120,114 221,362
2021-09-30 $8,340,004 179,548
2021-06-30 $6,031,422 150,861
2021-03-31 $3,225,000 60,000